000 | 01998 a2200685 4500 | ||
---|---|---|---|
005 | 20250514235516.0 | ||
264 | 0 | _c20051018 | |
008 | 200510s 0 0 eng d | ||
022 | _a0145-2126 | ||
024 | 7 |
_a10.1016/j.leukres.2005.02.015 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPerea, G | |
245 | 0 | 0 |
_aAdverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients. _h[electronic resource] |
260 |
_bLeukemia research _cOct 2005 |
||
300 |
_a1109-16 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAntibodies, Monoclonal |
650 | 0 | 4 |
_aBone Marrow _xmetabolism |
650 | 0 | 4 |
_aCD2 Antigens _xmetabolism |
650 | 0 | 4 |
_aCD36 Antigens _xmetabolism |
650 | 0 | 4 | _aChromosome Aberrations |
650 | 0 | 4 | _aChromosome Inversion |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunophenotyping |
650 | 0 | 4 | _aKaryotyping |
650 | 0 | 4 |
_aLeukemia, Myeloid _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aDomingo, A | |
700 | 1 | _aVillamor, N | |
700 | 1 | _aPalacios, C | |
700 | 1 | _aJuncà, J | |
700 | 1 | _aTorres, P | |
700 | 1 | _aLlorente, A | |
700 | 1 | _aFernández, C | |
700 | 1 | _aTormo, M | |
700 | 1 | _aQueipo de Llano, M P | |
700 | 1 | _aBargay, J | |
700 | 1 | _aGallart, M | |
700 | 1 | _aFlorensa, L | |
700 | 1 | _aVivancos, P | |
700 | 1 | _aMartí, J M | |
700 | 1 | _aFont, Ll | |
700 | 1 | _aBerlanga, J | |
700 | 1 | _aEsteve, J | |
700 | 1 | _aBueno, J | |
700 | 1 | _aRibera, J M | |
700 | 1 | _aBrunet, S | |
700 | 1 | _aSierra, J | |
700 | 1 | _aNomdedéu, J F | |
773 | 0 |
_tLeukemia research _gvol. 29 _gno. 10 _gp. 1109-16 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.leukres.2005.02.015 _zAvailable from publisher's website |
999 |
_c15733605 _d15733605 |